{"id":"https://openalex.org/W42620153","doi":null,"title":"[Medical and social implications of sexual dysfunction and safety of antihypertensive therapy in hypertensive patients].","display_name":"[Medical and social implications of sexual dysfunction and safety of antihypertensive therapy in hypertensive patients].","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W42620153","mag":"42620153","pmid":"https://pubmed.ncbi.nlm.nih.gov/22117681"},"language":"ru","primary_location":{"id":"pmid:22117681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22117681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kardiologiia","raw_type":"English Abstract"},"parent_works":[],"lineage":["https://openalex.org/W42620153"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072982429","display_name":"Arkadiy L. Vertkin","orcid":"https://orcid.org/0000-0001-8975-8608","observed_orcids":["https://orcid.org/0000-0001-8975-8608"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A L Vertkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048056743","display_name":"\u0424. \u0410. \u0412\u0438\u043b\u043a\u043e\u0432\u044b\u0441\u043a\u0438\u0439","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F A Vilkovyski\u012d","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011002694","display_name":"\u0410. \u0421. \u0421\u043a\u043e\u0442\u043d\u0438\u043a\u043e\u0432","orcid":"https://orcid.org/0000-0002-8856-3638","observed_orcids":["https://orcid.org/0000-0002-8856-3638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A S Skotnikov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084393175","display_name":"\u0415. \u0418. \u0417\u0432\u044f\u0433\u0438\u043d\u0446\u0435\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E I Zviagintseva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044857518","display_name":"\u0415. \u0412. \u0421\u043a\u043e\u0442\u043d\u0438\u043a\u043e\u0432\u0430","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E V Skotnikova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.0074809,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"51","issue":"10","first_page":"46","last_page":"52"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.5131999850273132,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.5131999850273132,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.41769999265670776,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11146","display_name":"Hormonal and reproductive studies","score":0.03180000185966492,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/erectile-dysfunction","display_name":"erectile dysfunction","score":0.8989999890327454},{"id":"https://openalex.org/keywords/testosterone-deficiency","display_name":"androgen deficiency","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.5230000019073486},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9459999799728394},{"id":"https://openalex.org/keywords/circadian-blood-pressure-variation","display_name":"circadian blood pressure variation","score":0.7239999771118164},{"id":"https://openalex.org/keywords/nocturnal-blood-pressure-decline","display_name":"nocturnal blood pressure dipping","score":0.7450000047683716},{"id":"https://openalex.org/keywords/aging-male-symptoms","display_name":"aging male symptoms","score":0.7210000157356262}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8789209127426147},{"id":"https://openalex.org/C2777733708","wikidata":"https://www.wikidata.org/wiki/Q192575","display_name":"Dipper","level":4,"score":0.8525479435920715},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.8222574591636658},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7534173727035522},{"id":"https://openalex.org/C2779929075","wikidata":"https://www.wikidata.org/wiki/Q184674","display_name":"Erectile dysfunction","level":2,"score":0.7034181356430054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6310018301010132},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.5505844950675964},{"id":"https://openalex.org/C2775871022","wikidata":"https://www.wikidata.org/wiki/Q7458776","display_name":"Sexual function","level":2,"score":0.5026321411132812},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.49827003479003906},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4665764272212982},{"id":"https://openalex.org/C2778093883","wikidata":"https://www.wikidata.org/wiki/Q1137463","display_name":"Sexual dysfunction","level":2,"score":0.44168925285339355},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4253895878791809},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.38808318972587585},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.3643803596496582},{"id":"https://openalex.org/C149323552","wikidata":"https://www.wikidata.org/wiki/Q3090739","display_name":"Ambulatory blood pressure","level":3,"score":0.2543365955352783}],"mesh":[{"descriptor_ui":"D000068756","descriptor_name":"Valsartan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007172","descriptor_name":"Erectile Dysfunction","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007172","descriptor_name":"Erectile Dysfunction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018660","descriptor_name":"Blood Pressure Monitoring, Ambulatory","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:22117681","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22117681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kardiologiia","raw_type":"English Abstract"},{"id":"mag:42620153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22117681","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W766552405","https://openalex.org/W2391067206","https://openalex.org/W2042236347","https://openalex.org/W2014327987","https://openalex.org/W2504589687","https://openalex.org/W2138521256","https://openalex.org/W2023547103","https://openalex.org/W2352875220","https://openalex.org/W2030099266","https://openalex.org/W2288703265"],"abstract_inverted_index":{"To":[0],"determine":[1],"the":[2,7,27,33,51,58,74,84,115,118,131,170,178,189,210],"effect":[3],"of":[4,19,22,43,53,57,80,96,117,120,172,180,212],"valsartan":[5,202],"on":[6,35],"androgen":[8,144,213],"status":[9],"and":[10,40,47,83,106,155,215],"erectile":[11,44,121,220],"function":[12,45],"in":[13,26,32,123,130,143,162,169,206],"hypertensive":[14,17,124],"patients.":[15],"60":[16],"patients":[18,30],"40-65":[20],"years":[21],"age":[23],"were":[24],"included":[25],"study.":[28],"All":[29],"filled":[31],"questionnaire":[34],"aging":[36],"male":[37],"symptoms":[38,119,146,211],"scale":[39],"international":[41],"index":[42],"before":[46],"3":[48],"months":[49],"after":[50,78],"course":[52],"antihypertensive":[54],"therapy.":[55],"Patients":[56],"first":[59,75],"group":[60],"received":[61],"angiotensin":[62,99],"II":[63],"receptor":[64],"antagonist":[65],"(valsartan)":[66],"as":[67],"monotherapy.":[68],"Valsacor":[69,112],"was":[70,86,108,160,166,196],"administered":[71],"starting":[72],"from":[73,88],"24":[76],"hours":[77],"destabilization":[79],"blood":[81,157,193,207],"pressure,":[82,208],"dose":[85],"titrated":[87],"80":[89],"up":[90],"to":[91,110,140,219],"160":[92],"mg/day.":[93],"Traditional":[94],"treatment":[95,113],"hypertension":[97],"including":[98],"converting":[100],"enzyme":[101],"inhibitors,":[102],"calcium":[103],"antagonists,":[104],"diuretics":[105],"beta-blockers":[107],"prescribed":[109],"controls.":[111],"reduced":[114],"intensity":[116],"dysfunction":[122],"males":[125],"(by":[126],"11,3":[127],"against":[128,148],"2,2%":[129],"control":[132,190],"group,":[133,191],"p<0,05).":[134],"In":[135,188],"addition,":[136],"this":[137],"therapy":[138,200],"led":[139],"a":[141],"decrease":[142],"deficiency":[145,214],"(20,2":[147],"12,1%,":[149],"respectively,":[150],"p":[151],"<":[152],"0,05).":[153],"Systolic":[154],"diastolic":[156],"pressure":[158,194],"reduction":[159],"comparable":[161],"both":[163],"groups.":[164],"There":[165],"an":[167],"increase":[168],"number":[171,179],"\"dippers\"":[173],"at":[174],"valsacor":[175],"treatment,":[176],"while":[177],"other":[181],"categories":[182],"(\"over-dipper\",":[183],"\"non-dipper\",":[184],"\"night-peaker\")":[185],"decreased":[186],"(p<0,05).":[187],"circadian":[192],"profile":[195],"not":[197,217],"changed.":[198],"Thus,":[199],"with":[201],"normalizes":[203],"diurnal":[204],"variations":[205],"reduces":[209],"does":[216],"contribute":[218],"dysfunction.":[221]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}